Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-β signaling pathway

Virology

Volumn 476, Issue , 2015, Pages 72-84

  Chi, Jia Qi ^a,b,c   Teng, Man ^b   Yu, Zu Hua ^a,b,f   Xu, Hui ^d   Su, Jing Wei ^b,c   Zhao, Pu ^b,c   Xing, Guang Xu ^b   Liang, Hong De ^c   Deng, Rui Guang ^b   Qu, Liang Hu ^d   Zhang, Gai Ping ^c,e   Luo, Jun ^b  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c HENAN AGRICULTURAL UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e YANGZHOU UNIVERSITY   (China)

^f HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

LTBP1; MDV; Mdv1 miR M4 5p; MicroRNA; MiR 155; Oncogenesis; TGF signaling

Indexed keywords

BINDING PROTEIN; LTBP1 PROTEIN; MESSENGER RNA; MICRORNA 155; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; MICRORNA; ONCOPROTEIN; VIRUS RNA;

ALPHAHERPESVIRINAE; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL ONCOGENE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; MARDIVIRUS; NATURAL HOST; NONHUMAN; ONCOGENE C MYC; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TARGETING; T CELL LYMPHOMA; ANIMAL; CHICKEN; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; MAREK DISEASE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; VIROLOGY;

GALLID HERPESVIRUS 2; HERPESVIRIDAE;

ANIMALS; BASE SEQUENCE; CHICKENS; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HOST-PATHOGEN INTERACTIONS; LATENT TGF-BETA BINDING PROTEINS; MAREK DISEASE; MICRORNAS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEIN P55(V-MYC); RNA, VIRAL; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84918776486     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.11.027     Document Type: Article

References (64)

1. Annes J.P., Chen Y., Munger J.S., Rifkin D.B. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J. Cell. Biol. 2004, 165:723-734.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Boss I.W., Plaisance K.B., Renne R. Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol. 2009, 17:544-553.
4. Burnside J., Bernberg E., Anderson A., Lu C., Meyers B.C., Green P.J., Jain N., Isaacs G., Morgan R.W. Marek[U+05F3]s disease virus encodes MicroRNAs that map to meq and the latency-associated transcript. J. Virol. 2006, 80:8778-8786.
5. Buscemi L., Ramonet D., Klingberg F., Formey A., Smith-Clerc J., Meister J.J., Hinz B. The single-molecule mechanics of the latent TGF-beta1 complex. Curr. Biol. 2011, 21:2046-2054.
6. Coupeau D., Dambrine G., Rasschaert D. The kinetic expression analysis of the cluster mdv1-mir-M9~M4, genes meq and vIL-8 differs between the lytic and latent phases of Marek[U+05F3]s disease virus infection. J. Gen. Virol. 2012, 93:1519-1529.
7. Davison A.J., Eberle R., Ehlers B., Hayward G.S., McGeoch D.J., Minson A.C., Pellett P.E., Roizman B., Studdert M.J., Thiry E. The order Herpesvirales. Arch. Virol. 2009, 154:171-177.
8. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 2009, 1792:497-505.
9. Frederick JP., Liberati NT., Waddell DS., Shi Y., Wang XF. Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 2004, 24:2546-2559.
10. Gomis R.R., Alarcón C., He W., Wang Q., Seoane J., Lash A., Massagué J. A FoxO-Smad synexpression group in human keratinocytes. Proc. Natl. Acad. Sci. USA 2006, 103:12747-12752.
11. Gottwein E., Corcoran D.L., Mukherjee N., Skalsky R.L., Hafner M., Nusbaum J.D., Shamulailatpam P., Love C.L., Dave S.S., Tuschl T., Ohler U., Cullen B.R. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe. 2011, 10:515-526.
12. Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.T., Braich R., Manoharan M., Soutschek J., Ohler U., Cullen B.R. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007, 450:1096-1099.
13. Haq K., Brisbin J.T., Thanthrige-Don N., Heidari M., Sharif S. Transcriptome and proteome profiling of host responses to Marek[U+05F3]s disease virus in chickens. Vet. Immunol. Immunopathol. 2010, 138:292-302.
14. Haecker I., Gay L.A., Yang Y., Hu J., Morse A.M., McIntyre L.M., Renne R. Ago HITS-CLIP expands understanding of Kaposi[U+05F3]s sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog. 2012, 8:e1002884.
15. Heldin C.H., Landstrom M., Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr. Opin. Cell. Biol. 2009, 21:166-176.
16. Higgs G., Slack F. The multiple roles of microRNA-155 in oncogenesis. J. Clin. Bioinform. 2013, 3:17.
17. Katz L.H., Li Y., Chen J.S., Munoz N.M., Majumdar A., Chen J., Mishra L. Targeting TGF-beta signaling in cancer. Expert Opin. Ther. Targets 2013, 17:743-760.
18. Kincaid R.P., Sullivan C.S. Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog. 2012, 8:e1003018.
19. Kong W., He L., Richards E.J., Challa S., Xu C.X., Permuth-Wey J., Lancaster J.M., Coppola D., Sellers T.A., Djeu J.Y., Cheng J.Q. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene 2014, 33:679-689.
20. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
21. Kunec D. Proteomics applied to avian herpesviruses. Avian Dis. 2013, 57:351-359.
22. Lan H.Y., Mu W., Nikolic-Paterson D.J., Atkins R.C. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody cross-reactivity and retrieve antigens. J. Histochem. Cytochem. 1995, 43:97-102.
23. Lei X., Zhu Y., Jones T., Bai Z., Huang Y., Gao S.J. A Kaposi[U+05F3]s sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor beta pathway to promote cell survival. J. Virol. 2012, 86:11698-11711.
24. Liu Y., Sun R., Lin X., Liang D., Deng Q., Lan K. Kaposi[U+05F3]s sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J. Virol. 2012, 86:1372-1381.
25. Louafi F., Martinez-Nunez R.T., Sanchez-Elsner T. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J. Biol. Chem. 2010, 285:41328-41336.
26. Luo J., Teng M., Fan J., Wang F., Zhou L., Deng R., Zhang G. Marek[U+05F3]s disease virus-encoded microRNAs: genomics, expression and function. Sci. China Life Sci. 2010, 53:1174-1180.
27. Luo J., Sun A.J., Teng M., Zhou H., Cui Z.Z., Qu L.H., Zhang G.P. Expression profiles of microRNAs encoded by the oncogenic Marek[U+05F3]s disease virus reveal two distinct expression patterns in vivo during different phases of disease. J. Gen. Virol. 2011, 92:608-620.
28. Massague J. TGFbeta in cancer. Cell 2008, 134:215-230.
29. Meyer N., Penn L.Z. Reflecting on 25 years with MYC. Nat. Rev. Cancer 2008, 8:976-990.
30. Miyazono K., Olofsson A., Colosetti P., Heldin C.H. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J. 1991, 10:1091-1101.
31. Morgan R., Anderson A., Bernberg E., Kamboj S., Huang E., Lagasse G., Isaacs G., Parcells M., Meyers B.C., Green P.J., Burnside J. Sequence conservation and differential expression of Marek[U+05F3]s disease virus microRNAs. J. Virol. 2008, 82:12213-12220.
32. Moustakas A., Pardali K., Gaal A., Heldin C.H. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol. Lett. 2002, 82:85-91.
33. Muylkens B., Coupeau D., Dambrine G., Trapp S., Rasschaert D. Marek[U+05F3]s disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Arch. Virol. 2010, 155:1823-1837.
34. Nair V., Kung H.J. Marek[U+05F3]s disease virus oncogenicity: molecular mechanisms. Marek[U+05F3]s Disease, An Evolving Problem 2004, 32-48. Elsevier Academic Press, Oxford. F. Davison, V. Nair (Eds.).
35. Osterrieder N., Kamil J.P., Schumacher D., Tischer B.K., Trapp S. Marek[U+05F3]s disease virus: from miasma to model. Nat. Rev. Microbiol. 2006, 4:283-294.
36. Parnas O., Corcoran D.L., Cullen BR. Analysis of the mRNA targetome of microRNAs expressed by Marek[U+05F3]s disease virus. mBio 2014, 5:e01060-13.
37. Parvizi P., Abdul-Careem M.F., Haq K., Thanthrige-Don N., Schat K.A., Sharif S. Immune responses against Marek[U+05F3]s disease virus. Anim. Health Res. Rev. 2010, 11:123-134.
38. Qian Z., Brunovskis P., Lee L., Vogt P.K., Kung H.J. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J. Virol. 1996, 70:7161-7170.
39. Rai D., Kim S.W., McKeller M.R., Dahia P.L., Aguiar R.C. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc. Natl. Acad. Sci. USA 2010, 107:3111-3116.
40. Rehmsmeier M., Steffen P., Hochsmann M., Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517.
41. Rifkin D.B. Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J. Biol. Chem. 2005, 280:7409-7412.
42. Ross N.L. T-cell transformation by Marek[U+05F3]s disease virus. Trends Microbiol. 1999, 7:22-29.
43. Samols M.A., Skalsky R.L., Maldonado A.M., Riva A., Lopez M.C., Baker H.V., Renne R. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog. 2007, 3:e65.
44. Seoane J., Le H.V., Shen L., Anderson S.A., Massagué J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004, 117:211-223.
45. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
46. Skalsky R.L., Samols M.A., Plaisance K.B., Boss I.W., Riva A., Lopez M.C., Baker H.V., Renne R. Kaposi[U+05F3]s sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 2007, 81:12836-12845.
47. Stik G., Laurent S., Coupeau D., Coutaud B., Dambrine G., Rasschaert D., Muylkens B. A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs. RNA 2010, 16:2263-2276.
48. Stik G., Dambrine G., Pfeffer S., Rasschaert D. The oncogenic microRNA OncomiR-21 overexpressed during Marek[U+05F3]s disease lymphomagenesis is transactivated by the viral oncoprotein Meq. J. Virol. 2013, 87:80-93.
49. Sun A.J., Petherbridge L., Zhao Y.G., Li Y.P., Nair V., Cui Z.Z. A BAC clone of MDV strain GX0101 with REV-LTR integration retained its pathogenicity. Chin. Sci. Bull. 2009, 54:2641-2647.
50. Tam W., Dahlberg J.E. miR-155/BIC as an oncogenic microRNA. Genes Chromosom. Cancer 2006, 45:211-212.
51. Tili E., Croce C.M., Michaille J.J. miR-155: on the crosstalk between inflammation and cancer. Int. Rev. Immunol. 2009, 28:264-284.
52. Waidner L.A., Morgan R.W., Anderson A.S., Bernberg E.L., Kamboj S., Garcia M., Riblet S.M., Ouyang M., Isaacs G.K., Markis M., Meyers B.C., Green P.J., Burnside J. MicroRNAs of Gallid and Meleagrid herpesviruses show generally conserved genomic locations and are virus-specific. Virology 2009, 388:128-136.
53. Wu K.J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat. Genet. 1999, 21:220-224.
54. Xu S., Xue C., Li J., Bi Y., Cao Y. Marek[U+05F3]s disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway. J. Virol. 2011, 85:276-285.
55. Yagi K., Furuhashi M., Aoki H., Goto D., Kuwano H., Sugamura K., Miyazono K., Kato M. c-Myc is a downstream target of the Smad pathway. J. Biol. Chem. 2002, 277:854-861.
56. Yao Y., Zhao Y., Xu H., Smith L.P., Lawrie C.H., Sewer A., Zavolan M., Nair V. Marek[U+05F3]s disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1. J. Virol. 2007, 81:7164-7170.
57. Yao Y., Zhao Y., Xu H., Smith L.P., Lawrie C.H., Watson M., Nair V. MicroRNA profile of Marek[U+05F3]s disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J. Virol. 2008, 82:4007-4015.
58. Yao Y., Zhao Y., Smith L.P., Watson M., Nair V. Novel microRNAs (miRNAs) encoded by herpesvirus of Turkeys: evidence of miRNA evolution by duplication. J. Virol. 2009, 83:6969-6973.
59. Yin Q., Wang X., Fewell C., Cameron J., Zhu H., Baddoo M., Lin Z., Flemington E.K. MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J. Virol. 2010, 84:6318-6327.
60. Yoshinaga K., Obata H., Jurukovski V., Mazzieri R., Chen Y., Zilberberg L., Huso D., Melamed J., Prijatelj P., Todorovic V., Dabovic B., Rifkin D.B. Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors. Proc. Natl. Acad. Sci. USA 2008, 105:18758-18763.
61. Yu Z.-H., Teng M., Sun A.-J., Yu L.-L., Hu B., Qu L.-H., Ding K., Cheng X.-C., Liu J.-X., Cui Z.-Z., Zhang G.-P., Luo J. Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek[U+05F3]s disease virus. Virology 2014, 448:55-64.
62. Yu Z.H., Teng M., Luo J., Wang X.W., Ding K., Yu L.L., Su J.W., Chi J.Q., Zhao P., Hu B., Zhang G.P., Liu J.X. Molecular characteristics and evolutionary analysis of field Marek[U+05F3]s disease virus prevalent in vaccinated chicken flocks in recent years in China. Virus Genes 2013, 47:282-291.
63. Zhao Y., Yao Y., Xu H., Lambeth L., Smith L.P., Kgosana L., Wang X., Nair V. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek[U+05F3]s disease virus. J. Virol. 2009, 83:489-492.
64. Zhao Y., Xu H., Yao Y., Smith L.P., Kgosana L., Green J., Petherbridge L., Baigent S.J., Nair V. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog. 2011, 7:e1001305.